New Two-Drug combo could supercharge deworming in african kids
NCT ID NCT06282315
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This large Phase 3 trial in Ghana and Kenya will test whether a single dose of a new albendazole-ivermectin combination pill works better than the standard albendazole alone to prevent soil-transmitted worm infections in 20,000 school-aged children. The study focuses on safety and how well the combo reduces worm infections. If it works, it could improve mass deworming programs across Africa.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
albendazole and ivermectin combination tablet
What this could lead to
If successful, this could provide a more effective single-dose treatment to prevent worm infections in millions of children, reducing disease spread.
What could go wrong
This is a large trial, but the new combination may cause more side effects than the standard drug, and results may vary by region or worm type.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOIL-TRANSMITTED HELMINTHS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ghana Health Service (GHS)
RECRUITINGAccra, Accra, Ghana
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
Kenya Medical Research Institution (KEMRI)
RECRUITINGNairobi, Nairobi County, 00200, Kenya
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••